Human Health Segment to Lead MENAT Syringe Market During 2021–2028

According to our latest study on "MENAT Syringe Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Syringe Type, Application, Usability, and End User," the market is expected to grow from US$ 882.66 million in 2021 to US$ 1,570.79 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2022 to 2028. The report highlights the key factors driving and restraining the market growth, prominent players with their developments in the market, and trends prevailing in the market.

A syringe is a piston-like medical instrument that has significant importance in healthcare. Syringes play a major role in administering vaccines, nutritional supplements, and medicines. The product has a wide range of applicability, from injecting liquid nutritionals into a feeding tube to conducting vaccination. Syringes can be classified into reusable and disposables. Growing prevalence of chronic and infectious diseases and increasing adoption of injectable drugs drive the MENAT syringe market. However, the increase in cases of needlestick or sharp injuries (NSIs) hampers the market's growth.

Based on application, the MENAT syringe market is segmented into aesthetics, human health, lab / industrial, and others. The human health segment held the largest share of the market in 2021. However, the aesthetics segment is anticipated to register the highest CAGR in the market during the forecast period. The adoption rate of syringes in the human health segment is the highest, which can be attributed to increasing prevalence of chronic disease, rising number of surgical procedures, and increasing demand for vaccines and immunization. Chronic diseases such as diabetes and rheumatoid arthritis can be treated through the self-administration of drugs using syringes. Furthermore, government organizations have been funding companies engaged in manufacturing disposable syringes that can be used during the treatment of COVID-19 patients. Key companies are also offering technologically advanced syringes to increase their market share in the healthcare market. For instance, in August 2019, U.S. FDA approved Eylea (aflibercept) Injection prefilled syringe developed by Regeneron Pharmaceuticals. This is a single-dose prefilled syringe that requires fewer steps of preparation as compared to vials. It is recommended for the treatment of diabetic retinopathy, diabetic macular edema, wet age-related macular degeneration, and macular edema following retinal vein occlusion.

Impact of COVID-19 on MENAT Syringe Market

The mortality rate of patients in low-cost regions soared because healthcare professionals had limited their patient check-ups as many hospitals experienced a shortage of resources and staff. The COVID-19 pandemic increased the demand for syringes and positively influenced the MENAT syringe market. Since the beginning of the pandemic, the Abu Dhabi Medical Supplies Company has provided the local health sector with more than 10 million homemade medical syringes and needles of high quality at competitive prices. Additionally, in July 2021, Morocco invested US$ 500 million in launching its COVID-19 vaccine manufacturing project. Morocco launched the project with a production capacity of five million doses of COVID-19 vaccines per month. Additionally, in January 2022, after setting up a manufacturing unit for vaccine syringes, Morocco canbecome a part of the worldwide COVID-19 vaccine supply chain and can fulfill its ultimate objective of reaching vaccine self-sufficiency. The syringe manufacturing unit is the first stage of a three-stage plan that includes a vaccine research-development stage. The production unit in Benslimane is expected to produce 160 units by the end of 2022, covering Morocco’s vaccine needs. The production capacity will increase in 2025 to reach 900 million units. Thus, the above-mentioned factors supported the growth of the market.

Becton Dickinson and Co., Baxter International Inc, Vita Needle Co, B. Braun SE, Terumo Corp, Abu Dhabi Medical Devices Co., Cardinal Health Inc., Nipro Corp, Hindustan Syringes & Medical Devices Ltd, and Ypsomed AG are among the leading companies operating in the MENAT syringe market.

The report segments the MENAT syringe market as follows:

The MENAT syringe market is segmented based on syringe type, application, usability, and end user. Based on syringe type, the market is segmented into luer lock syringes, glass syringes, luer slip syringes, and others. In terms of application, the market is categorized into aesthetics, human health, lab / industrial, and others. Based on usability, the market is segmented into sterilizable/reusable syringes and disposable syringes. Based on end user, the market is categorized into hospitals & clinics, blood collection centers, diabetic care centers, and others. Based on country, the MENAT syringe market is segmented into Saudi Arabia, the UAE, South Africa, Turkey, Egypt, Morocco, and Rest of Middle East & Africa..

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com